Clinical Trials Logo

Clinical Trial Summary

The investigators seek to characterize the identity of all microorganisms residing on the eye's surface (conjunctiva) in healthy eyes and those with dry eye syndrome, using a combination of analyses. Dry eye disease is thought to have an inflammatory basis and in the vast majority of cases the cause of the chronic inflammatory condition is unknown.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02306668
Study type Observational
Source University of Washington
Contact Sue Rath, COT
Phone 206-897-4331
Email raths@uw.edu
Status Recruiting
Phase N/A
Start date February 2014
Completion date December 2016

See also
  Status Clinical Trial Phase
Completed NCT01933178 - Reproducibility of Anterior Segment Optical Coherence Tomography (AS-OCT) for Imaging Conjunctivochalasis N/A
Completed NCT01933165 - Reproducibility of LipiView Ocular Surface Interferometer (LipiView) for Measuring Tear Lipid Layer Thickness N/A
Completed NCT01988597 - Dry Eye Symptoms and Quality of Life N/A
Withdrawn NCT02123147 - Examining the Immunological Process of Autoimmune Patients N/A
Terminated NCT01450787 - Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics N/A
Completed NCT06071780 - Virgin Coconut Oil Contact Lens as Ocular Rewetting Agent N/A
Completed NCT01918410 - Effect of Contact Lens With Alginic Acid in Dry Eye Patients N/A
Completed NCT01991132 - Validating the Diagnostic Accuracy of Mediview 2.0 Software as an Image Analysis Tool of Meibomian Glands N/A
Completed NCT01679015 - Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes N/A
Completed NCT01682460 - Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients Phase 4
Completed NCT01695668 - Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5% N/A
Enrolling by invitation NCT02153515 - Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous Blood Phase 3